Cubist Systematic Strategies’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.65K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $786K | Sell |
|
|||||
|
2023
Q1 | $2.12M | Buy |
|
|||||
|
2022
Q4 | $135K | Sell |
|
|||||
|
2022
Q3 | $1.18M | Sell |
|
|||||
|
2022
Q2 | $2.12M | Buy |
|
|||||
|
2022
Q1 | $520K | Buy |
|
|||||
|
2021
Q4 | $351K | Sell |
|
|||||
|
2021
Q3 | $485K | Sell |
|
|||||
|
2021
Q2 | $1.18M | Sell |
|
|||||
|
2021
Q1 | $4.78M | Buy |
|
|||||
|
2020
Q4 | $1.8M | Sell |
|
|||||
|
2020
Q3 | $3.14M | Buy |
|
|||||
|
2020
Q2 | $498K | Sell |
|
|||||
|
2020
Q1 | $411K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $484K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $184K | Buy |
|